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Abstract: Extra virgin olive oil (EVOO), one of the key foods of the Mediterranean diet, is distin-
guished by its high content of nutritional and antioxidant compounds compared to other vegetable
oils. During EVOO production, the major secoiridoids of EVOO, oleacein, oleocanthal, ligstroside,
and oleuropein aglycones, undergo a series of transformations to open- and closed-structure forms.
The resulting mixture of compounds can become more complex during the analytical procedure,
due to the keto-enol tautomerism of the open forms and their interaction with polar solvents, and
therefore more challenging to analyze. Employing the same extraction method used to analyze the
other EVOO phenolic compounds, we report here a simple UHPLC-ESI-MS/MS procedure for the
quantification of those secoiridoids that is able to co-elute the different isomers of each compound.
The method was validated following AOAC guidelines, and the matrix effect and recoveries were
within satisfactory limits.
Keywords: EVOO analysis; polyphenols; Mediterranean diet; oleocanthal; oleacein; HPLC; mass
spectrometry
1. Introduction
Extra virgin olive oil (EVOO) is the main fat of the Mediterranean Diet and its con-
sumption is related to some health benefits as protection against cancer [1], type II dia-
betes [2], neurodegeneration [3], cardiovascular diseases, and reduces total mortality [4].
Those are attributed to its fatty acid profile, rich in mono-unsaturated fatty acids, and to its
non-saponifiable fraction, rich in antioxidants [5]. The non-saponifiable fraction is com-
posed by lipophilic compounds as vitamins, mainly α-tocopherol; and carotenoids, mostly
lutein and β-carotene; and a more hydrophilic molecules as phenolic compounds, above
all, secoiridoids (SEC). This fraction, in addition to its health benefits, is the responsible of
EVOO high appreciated taste. The volatiles compounds are responsible of its aroma, giving
to it from notes of green fruit to notes of banana. Moreover, the phenolic compounds are
well correlated with bitter, fruity, green, and pungent EVOO taste descriptors [6].
SEC represent 70–90% of the total phenolic compounds in EVOO [7]. Among the major
SEC in olive drupes are oleuropein and ligstroside [8,9], which evolve to their constituent
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aglycones of oleuropein (OLA) and ligstroside (LIG) during EVOO production. The hy-
drolyzation of glycosidic bonds during the crushing and malaxation processes leads to the
formation of aglycones, primarily in the non-aldehydic closed form [10]. The initial aglycone
compounds (closed form I) are then transformed by hydrolysis and keto-enol tautomerism
into the open forms I and II (dialdehyde) and by a 1,4-Michael addition into the closed
forms II and III (mono-aldehydes) [10,11]. These transformations can take place because the
pH of the olive paste is approximately five and the compounds undergo an isomerization
reaction with the acid in the water phase. Additionally, oleacein (OLE) and oleocanthal
(OLC), also with open and closed forms, are generated through a decarboxylation step. The
proposed processes of biotransformation and isomerization are depicted in Figure 1.
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Figure 1. Conversion of Oleuropein and Ligstroside to oleuropein aglycone (OLA), oleacein (OLE),
ligstroside aglycone (LIG), and oleocanthal (OLC) during oil extraction. Adapted from Abbattista
et al., 2019 [10] and adding the closed forms I and II for OLC and OLE, which are possible artifacts.
Those phenolic compounds are the responsible of some EVOO health effects [12].
OLC is found to be a nonsteroidal anti-inflammatory compound, with effect similar to
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ibuprofen [13]. Furthermore, consumption of EVOO rich in OLC is associated with an
anti-platelet effect, which may affect the prevention of cardiovascular diseases [14]. OLC
also plays a remarkable role against neurogenerative diseases, primarily it reduces ox-
idative stress and protects against neuronal apoptosis [15]. It plays specific roles against
Alzheimer’s Disease, it inhibits β-amyloid formation, reduces its toxicity and enhances
the clearance from the brain [16–18]. On the other hand, OLE prevents cardiovascular
diseases by inhibiting LDL oxidation and preventing neutrophil adhesion [19,20]. OLE
also has anti-cancer effect promoting apoptosis in leukemia and skin cancer cells [21,22].
LIG also has shown anti-cancer effect, against breast cancer cells inducing apoptosis [23]
and inhibiting c-MET signaling and then having antimigratory activity [24]. Finally, OLA
has proven to reduce the levels of total cholesterol, LDL, and triglycerides and to increase
HDL and liver antioxidant enzymes in vivo [25].
SEC concentration in EVOO depends on different agronomical and technical factors.
For instance, the variety is the most affecting factor [26]. For example, varieties such as
the Spanish “Picual” or the Italian “Coratina” contain high concentrations in SEC [26,27].
Additionally, there are some Ivory-wild varieties that produce an EVOO very rich in
SEC [28]. Another factor that affects SEC concentration is the maturity stage of the olives.
The different enzymatic activities of the olive varieties cause the phenolic profile to vary
distinctly during the ripening [27]. Moreover, technical factors also play an important role
during EVOO extraction, an increase in the malaxation temperature will lead to an increase
in enzymatic activity during EVOO extraction [29]. In addition, an increase in malaxation
time will increase the time those enzymes are working, having more reaction from LIG
and OLA to OLC and OLE, respectively, then increasing OLC and OLE concentration and
decreasing LIG and OLA [30]. Finally, the type and diameter of sieve also affect the oil
composition [31]. Thus, an accurate analysis of those compounds could shed light on how
agronomical and technical factors affect the bioactive components of EVOO.
Different methods are available for the analysis of EVOO phenolic compounds [32,33],
but liquid chromatography coupled to mass spectrometry (MS) has proven to be the
best in terms of selectivity and limits of detection (LOD) and quantification (LOQ) [34].
Colorimetric methods have been well correlated with individual phenols, although they
only give an idea of the total amount and not of the phenolic profile of the oil [35]. However,
during the chromatographic analysis, the open-structure forms of the four main SEC of
EVOO can undergo keto-enol tautomerism, and monohydrates, methyl hemiacetals and
dimethyl acetals can be generated when the sample is prepared with water and methanol
(MeOH). Therefore, chromatographic analysis of those SEC has several impediments. In
addition, the open-ring forms I and II (dialdehyde), closed form I (non-aldehyde) and
closed forms II and III (mono-aldehyde) can be detected when OLA and LIG are in contact
with a protic solvent such as water [10,36,37]. SEC can also form acetals and hemi-acetals
with MeOH and water [38]. Curiously, the methyl hemi-acetal of OLC has been previously
detected in EVOO but not identified, being reported as unknown [39].
The methods of Suarez et al. (2008) resulted in wide and jagged peaks for OLC
and OLE [40]. To block the carbonylic species and avoid the tautomeric equilibrium and
interaction with solvents, Di Donna et al. (2011) proposed carrying out in situ chemi-
cal derivatization of the aldehyde functions with methoxyamine before the analysis of
OLC and OLE with high-performance liquid chromatography (HPLC) coupled with mass
spectrometry in tandem (MS/MS), but this extra step resulted in a more complicated and
expensive method [41]. Alternatively, Karkoula et al. (2012) developed a quantitative
1H-NMR method for the analysis of the dialdehyde forms of OLC and OLE [42], which
was later extended to the analysis of the closed monoaldehyde forms of the aglycones [43].
However, a large amount of EVOO (5 g) and solvents (50 mL) are required to ensure a
sufficient quantity of analytes in the sample, and the extract cannot be used for the analysis
of the other phenolic compounds. Another disadvantage is that this method also needs an
external calibration curve, as the extraction is not complete, requiring then large amounts of
pure compounds, although this calibration curve is just needed once, as the NMR response
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is constant. Furthermore, the method cannot quantitate all isoforms of LIG and OLA, just
the closed monoaldehyde forms. (closed forms II Figure 1). Diamantakos et al. (2015)
determined that the ratio of the open dialdehyde forms and the open monoaldehyde form
(the corresponding enolic form) was 1:1:2, respectively [37]. Later, the same authors used
the 1:1:2 ratio to calculate also the concentration of these form integrating the enol peak of
the open monoaldehyde form [44]. However, the reagent and time-consuming problem of
the extraction required for the NMR analysis is not solved.
Sánchez de Medina et al. (2017) developed a method to determine OLC and OLE, but
not the other EVOO SEC [38]. In addition, in later experiments, they also quantitate OLA
and LIG, but without method validation [45]. Moreover, Celano et al. (2018) studied the
SEC transformations during the extraction and chromatographic process and validated a
method for the quantitation of SEC through ultra-high performance liquid chromatography
(UHPLC) coupled to a UV detector. However, this approach is time-consuming (27 min)
and the LOD and LOQ are high [46]. Finally, a direct method for the analysis of SEC
by UHPLC coupled to MS/MS, minimizing the generation of acetals and hemiacetals,
was recently validated. Nevertheless, a separate extraction process was required, as the
extraction method proved unsuitable for the other phenolic compounds [47]. Furthermore,
a ternary pump and a chromatographic instrument adequate for strong organic solvents,
not always available, were also necessary.
Herein we report the development and validation of a simple analytical method based
on UHPLC coupled with electrospray ionization and MS/MS (UHPLC-ESI-MS/MS) for
the analysis of the four major SEC compounds in EVOO, able to coelute their isomers and
achieve well-shaped peaks. Matrix-matched calibration was used, employing the same
extraction process as for the other phenolic compounds in EVOO and a defatting step. The
matrix effect of the oil and the analyte recoveries were also assessed.
2. Materials and Methods
2.1. Reagents
OLC (≥95% purity) was purchased from Merck (Darmstadt, Germany), and OLE
(≥90% purity) and OLA (≥95% purity) from Toronto Research Chemicals (North York,
ON, Canada). MeOH, acetonitrile (ACN) and formic acid were acquired from AppliChem,
Panreac Quimica SLU (Barcelona, Spain). Hexane, 4-hydroxybenzaldehyde, chloroform-d,
tetramethylsilane and gentisic acid were purchased from Sigma-Aldrich (St. Louis, MO,
USA). 3-(4-hydroxy-3-methoxyphenyl)propionic acid was purchased from Fisher Scientific
(Waltham, MA, USA) and cyclohexane from Carlo Erba (Madrid, Spain). Ultrapure water
was obtained using a Milli-Q purification system (Millipore, Bedford, MA, USA).
2.2. SEC Extraction for UHPLC-ESI-MS/MS Analysis
SEC were extracted by a liquid-liquid extraction following the procedure proposed
by Capriotti et al. (2014) [48]. Briefly, 0.5 g of EVOO was dissolved in 1 mL of hexane in
a 10 mL centrifuge tube and shaken for 30 s. The phenolic compounds were extracted as
follows: 2 mL of a solution of MeOH:water (4:1 v/v) was added to the tube and stirred
for 30 s. The resulting emulsion was centrifuged at 3000 rpm and 4 ◦C for 3 min. After
separation of the hexane phase, the methanolic-aqueous extract was washed with hexane.
To ensure the complete removal of SEC from the hydrophobic phase, a second extraction of
phenolic compounds was carried out from the hexane phase with MeOH:water (4:1 v/v),
using the aforementioned conditions. The combined methanolic-aqueous extracts were
evaporated under a nitrogen curtain and reconstituted with 800 µL of MeOH:water (80:20
v/v), filtered with polytetrafluoroethylene syringe filters (0.2 µm), transferred to an amber
glass vial, and stored at −80 ◦C until analysis. All procedure was done under UV-filtered
light to avoid SEC photooxidation.
The calibration curve was prepared in refined olive oil, which was spiked with the
standards before extraction at the following concentrations: 1, 2, 5, 8, 10, and 20 mg·kg−1.
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2.3. UHPLC-ESI-MS/MS Analysis
The analysis was carried out using a UHPLC Acquity system equipped with a bi-
nary pump and autosampler (Waters, Milford, MA, USA), coupled to an API3000 triple
quadrupole mass spectrometer (ABSciex, Framingham, MA, USA) equipped with a Tur-
boIonspray source operating in negative mode. An Acquity UPLC® BEH C18 column
(2.1 × 50 mm, i.d., 1.7 µm particle size) with an Acquity UPLC® BEH C18 pre-column
(2.1 × 5 mm, i.d., 1.7 µm particle size) (Waters Corporation®, Dublin, Ireland) were used
for the main SEC separation. The mobile phases consisted of MeOH with 0.1% of formic
acid (A) and water with 0.1% of formic acid (B) and the flow was constant at a rate
0.6 mL·min. The gradient was as follows: t = 0 min, 100% (A); t = 2 min, 100% (A);
t = 4.75 min, 46.4% (A); t = 4.9 min, 0% (A); t = 5.9 min, 0% (A); t = 6 min, 100% (A);
t = 6.5 min, 100% (A). The injection volume and column temperature were 5 µL and 50 ◦C,
respectively.
Ionization, in negative mode, was achieved using electrospray ionization (ESI) and
all the compounds were monitored in the multiple monitoring mode (MRM) with the
following settings: capillary voltage, −4000 V; nebulizer gas (N2), 10 (arbitrary units);
curtain gas (N2), 12 (arbitrary units); and drying gas (N2) heated to 450 ◦C at flow rate
8000 c/min. The declustering potential, focusing potential, collision energy and entrance
potential are shown in Table 1. The system was controlled by Analyst version 1.4.2 software
supplied by ABSciex, the chromatograms were integrated with this same software.
Table 1. Electrospray ionization parameters for the secoiridoids (SEC).
OLE OLC OLA LIG
MRM Transition 361/291 303/285 377/275 319/69
Declustering Potential −40 −40 −45 −30
Focusing Potential −170 −170 −140 −170
Entrance Potential −5 −5 −5 −5
Collision Energy −10 −10 −15 −30
Dwell Time (ms) 150 50 150 50
Retention time (min) 2.7 2.4 2.5 2.3
2.4. Validation of the UHPLC-ESI-MS/MS Method
The method was validated following the AOAC guidelines for dietary supplements
and botanicals [49]. A matrix-matched calibration was selected, as previous experiments
show low analyte recoveries [40]. The standards used were OLC, OLE, and OLA, but not
LIG, as it is not commercially available. Selectivity, linearity, accuracy, repeatability, the
carry-over between samples and the LOD and LOQ were tested. Regarding the selectivity,
the ability to distinguish the analyte from other substances was indicated by an absence
of the respective peaks at the same retention time as the corresponding standards in trace
chromatograms obtained in multiple monitoring mode.
For assessing the cleaning step of the chromatographic method, the carry-over was
evaluated. The carry-over is the increment of the signal of a peak due to residual analyte
from preceding sample that remains in the instrument [50]. As AOAC guidelines do not
have a protocol to evaluate the carry-over, the guideline on bioanalytical method validation
from the European medicines agency was followed [50]. Hence, a blank sample was
injected after the highest peak of the calibration curve (20 mg·kg−1) and the carry-over
should not be greater than 20% of the LOQ.
The linearity was evaluated by developing calibration curves using refined olive
oil spiked with the analytes before the extraction, with 6 concentration points ranging
from 1 to 20 mg·kg−1 and five replicates for each point. The residuals were then tested
through a residual plot. The R2 was also calculated, as were the accuracies of each point
of the curve, based on the ratio between the calculated concentration and the spiked
concentration; following AOAC guidelines, accuracies between 80 and 120% were accepted
as valid. When necessary, weighted regression was applied to improve the accuracy [51].
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For calculating the curves with weighting, and without it, and for the residual plot test R
version 4.0.3 (The R foundation) with RStudio version 1.3.1 (Rstudio, PBC) software was
used. For the rest of the calculus, Excel 2017 (Microsoft SA) software was used.
To determine the repeatability of the method, both intra- and inter-day repeatability
were tested. Five replicates of a low-, intermediate- and upper-point of the curve (1, 5, and
10 mg·kg−1) were injected three times on the same day for the intra-day and three times
on three different days for the inter-day repeatability. The relative standard deviations
(RSD) for the inter- and intra-day experiments were calculated. All the values lower than
RSD = Concentration−(0.15) were accepted. Those values are lower than 8% for 1 mg·kg−1,
7% for 5 mg·kg−1 and 6% for 10 mg·kg−1.
The LOD is the smallest concentration of the analyte that can be distinguished from
the blank and by definition is 3 times the standard deviation of the blank. The LOQ is the
smallest amount or concentration of an analyte that can be determined with acceptable
reliability and corresponds to 10 times the standard deviation of the blank. The LOD and
LOQ were determined using the lower point of the curve, calculating the signal-to-noise
ratio of that point, and extrapolating the concentration with a signal-to-noise ratio of 3 and
10, respectively. Then each analyte was prepared at the LOD and LOQ concentration to
verify the obtained value.
2.5. Matrix Effect and Recovery
The matrix effect and the recovery of the developed method were assessed following
the procedure of Matuszewski et al. (2003) [52]. The matrix effect is the change of the
analyte signal due to coeluted substances, whilst the recovery is the percentage of the
analyte that remains after the extraction. Three different calibration curves were prepared,
two of them using refined olive oil spiked with the standard SEC compounds before and
after the extraction process, named “spiked-before” and “spiked-after” curves (SBC and
SAC, respectively). The third curve was generated by directly diluting the standards in the
reconstitution phase, namely, the reconstitution phase curve (RPC). By comparing the SBC
and SAC, it is possible to evaluate the recovery of the extraction. Whereas the matrix effect
can be assessed by comparing the SAC and RPC, as the interferences form the matrix are
not present in the RPC.
3. Results and Discussion
3.1. Analytical Method Development
The chromatographic conditions were established as in a previous study [38]. Different
percentages of formic acid (from 0.02% to 1%) in both mobile phases were tested to improve
the peak shape and ionization of the SEC. The best ionizations were achieved with 0.1%
of formic acid in both water and MeOH. The ionization parameters were then optimized
for each compound to obtain the highest signal through direct infusion of the analytes at
1 mg·L−1. The parameters optimized were the declustering potential, focusing potential,
collision energy, and entrance potential. Finally, the dwell time was optimized to obtain a
smooth peak. The results are shown in Table 1.
As already mentioned, the coexistence of open- and closed-structure forms of SEC
compounds hinders their chromatographic analysis. However, we improved the gradient
to minimize the number of peaks for each compound and obtained thin and symmetric
peaks. These new chromatographic conditions allowed us to coelute the different iso-
mers together, all of which could thus be quantified at the same time. An example of
a chromatogram for each analyte is shown in Figure 2. OLE and OLC isoforms were
eluted in one peak, whereas OLA and LIG still produced more than one, although with
acceptable accuracy.
Finally, when analyzing oil samples with a reverse phase column, sometimes the
chromatographic conditions cannot properly clean the column and cross-contamination
of samples can occur. To prevent this, Luque et al. (2019) implemented a cleaning step
based on ACN and tetrahydrofuran, requiring a ternary pump system and an HPLC
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instrument prepared for strong solvents, which are not always available [47]. In our
study, the chromatographic cleaning step was confirmed by testing the carry-over in a
blank sample injected right after the most concentrated point of the calibration curve
(20 mg·kg−1). The carry-over for OLE was null, in the case of OLC and OLA, despite being
a small peak, it was less than 20% of the LOQ. The chromatograms are showed in Figure S1.
As the extraction method includes a defatting step with hexane, the use of strong organic
solvents was not needed to avoid carry-over.
Figure 2. Example chromatogram of oleacein (A), oleocanthal (B), oleuropein aglycone (C), and ligstroside aglycone (D),
the latter from a commercial “Picual” EVOO.
Additionally, the use of an internal standard was tested to minimize errors. The best in-
ternal standards for a MS quantitation method are compound analogues isotopically labeled
with deuterium (D) or 13C, but OLA, LIG, OLE, and OLC derivatives are not commercially
available. Therefore, compounds structurally similar to our target analytes were tested
as internal standards, such as gentisic acid and 3-(4-hydroxy-3-methoxyphenyl)propionic
acid. Those were tested at 5 mg·kg−1, corresponding to an intermediate concentration of
the calibration curve. However, the resulting accuracies were lower than without the use
of internal standards.
3.2. Analytical Method Validation
The method was assessed in terms of linearity, selectivity, accuracy, repeatability, and
LOD and LOQ (results shown in Table 2). The selectivity was visually checked in the
chromatograms, which showed no other analytes except those of interest.
The linearity range was examined visually in the residual plot. In the case of OLC and
OLA, a 1/x2 and 1/x weighting was used, respectively, to improve the accuracy for the
low concentration points [51]. Then, as the curve was built with a weighted least squares
method, the linearity was checked through the standardized residual plots (depicted in
Figure S2). All the three analytes (OLC, OLE, and OLA) showed linearity in the tested
range between 1 and 20 mg·kg−1. Other studies report linearity from 3 to 200 µg·kg−1 for
OLE and LIG, from 1 to 100 µg·kg−1 for OLA, and from 12 to 800 µg·kg−1 for OLC [47].
However, those margins are far below the usual concentration of these compounds in
EVOO [45].
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Table 2. Method validation parameters for OLE, OLC, and OLA.
OLE OLC OLA
Calibration curve
Slope 27,987 33,800 82,737
Interception −19,765 −7875 −74,897
R2 0.9991 0.9873 0.9907
Weighting none 1/x2 1/x
Limits
LOD (mg·kg−1) 0.0343 0.0186 0.0334
LOQ (mg·kg−1) 0.114 0.0621 0.111
Accuracies
1 mg·kg−1 93% 107% 87%
2 mg·kg−1 100% 89% 101%
5 mg·kg−1 103% 97% 113%
8 mg·kg−1 96% 95% 98%
10 mg·kg−1 102% 100% 110%
20 mg·kg−1 99% 114% 94%
Repeatability Relative
Standard Deviation
Intraday 1 mg·kg−1 2.3% 2.5% 5.8%
Intraday 5 mg·kg−1 1.9% 2.7% 1.8%
Intraday10 mg·kg−1 1.1% 5.7% 3.7%
Interday 1 mg·kg−1 2.4% 3.3% 7.5%
Interday 5 mg·kg−1 5.7% 4.1% 7.0%
Interday 10 mg·kg−1 1.2% 6.0% 3.1%
The LODs were in the order of 20 µg·kg−1 and LOQs approximately 100 µg·kg−1,
which are sufficiently low to quantitate the SEC in EVOO [45]. The limits are higher than
those reported by Luque et al. who reported a LOD of about 1 µg·kg−1 and LOQ of about
3 µg·kg−1, with even lower values for OLA (0.3 µg·kg−1 and 0.9 µg·kg−1, respectively) [47].
An explanation for these different results is that Luque-Muñoz et al. were using a more
sensitive mass spectrometer (a Xevo TQS tandem quadrupole mass spectrometer from
Waters) than the one used in this work. However, the LOD and LOQ of our method were far
lower than those achieved with the 1H-NMR procedure published by Karkoula et al. (2014),
in which the LOD was 1 mg·kg−1 and the LOQ was 10 mg·kg−1 for all compounds [43].
These high values are due to the analytical technique, as NMR is less sensitive than MS [53].
The LOD and LOQ obtained here are also lower than those reported by Suarez et al. [40].
Further comparison between methods is summarized in Table 3.












0.0343 0.114 0.999 1.8 0.5 UHPLC-ESI-MS/MS 6.5 Current study
0.128 0.428 - 3.1 45 UPLC-ESI-MS/MS 40 [40]
0.002 0.005 0.999 10 1 HPLC-ESI-MS/MS 10 [38]
0.001 0.0033 0.995 1.9 1 UHPLC-ESI-MS/MS b 7.5 [47]
1 10 0.994 4.3 5 NMR - [42]
OLC
0.0186 0.0621 0.987 3.6 0.5 UHPLC-ESI-MS/MS 6.5 Current study
0.072 0.244 - 3 45 UPLC-ESI-MS/MS 40 [40]
0.004 0.01 0.992 11 1 HPLC-ESI-MS/MS 10 [38]
0.004 0.012 0.994 4.4 1 UHPLC-ESI-MS/MS b 7.5 [47]
1 10 0.999 4.3 5 NMR - [42]
OLA
0.0334 0.111 0.991 3.8 0.5 UPLC-ESI-MS/MS 6.5 Current study
0.0003 0.0009 0.996 2.5 1 UHPLC-ESI-MS/MS b 7.5 [47]
1 10 0.999 4.1 5 NMR - [43]
The parameters were chosen according to the criteria of the authors to help choose the most suitable analytical method. a Relative standard
deviation within the same day of analysis, when it was calculated for more than one concentration; the mean of the different RSD is showed
in the table. b The chromatographic instrument requires a ternary pump and to be prepared for strong organic solvents.
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The accuracy of the method was within the accepted limits of the AOAC guidelines
(80–120%) for all the concentrations and analytes. Other studies report similar results: the
accuracies found by Luque et al. are all less than 15% and those of Karkoula et al. (2012)
are less than 16% [42,47].
Lastly, both the intra and inter-day repeatability of the method were within the
accepted margins established by AOAC guidelines, which stipulate that the maximum RSD
should be 6% for 10 mg·kg−1, 7% for 5 mg·kg−1 and 8% for 1 mg·kg−1. Similarly, Luque
et al. reported an RSD between 2.5 and 8.5% for OLC at 594 ng·mL−1 and 24.75 ng·mL−1,
respectively [47]. In contrast, Sanchez de Medina et al. showed higher deviations, being 10%
for OLC and 11% for OLE, although in this case the concentrations were not specified [38].
3.3. Matrix Effect and Recovery
Table 4 shows the results of the matrix effect and the recoveries for each concentration
of the curves and compound, calculated as described above. The recoveries for the phenolic
extractions were partial and varied according to the compound and concentration, ranging
between 50 and 100%. Suarez et al. also found quite low recoveries for OLC (67%) and
OLE (71%) [40].
Table 4. Matrix effect and recoveries for OLE, OLC, and OLA.
OLE OLC OLA
Matrix effect (%)
1 mg·kg−1 56 93 20
2 mg·kg−1 50 76 27
5 mg·kg−1 86 129 57
8 mg·kg−1 79 123 51
10 mg·kg−1 82 134 56
20 mg·kg−1 93 152 69
Recoveries (%)
1 mg·kg−1 55 59 66
2 mg·kg−1 98 96 88
5 mg·kg−1 80 61 74
8 mg·kg−1 96 62 106
10 mg·kg−1 89 61 88
20 mg·kg−1 94 60 93
Matrix effect was observed due to the substances coextracted and coeluted in the
chromatography with the phenols. In the case of OLE and OLA, the matrix effect was less
than 100%, indicating matrix suppression; the values ranged from 50 to 90% for OLE and
20 to 69% for OLA. On the contrary, matrix enhancing was observed for OLC, with values
ranging from 75 to 150%.
To minimize the error due to the matrix effect and recoveries, internal standard
method, or matrix-matched method are suitable, both make the matrix effect and the
recoveries the same for the curve and the samples, although the internal standard method
does not need a white matrix. In this study a matrix-matched external calibration was
carried out to validate the method, it was possible to use this calibration method as the
refined olive oil served as a blank matrix.
4. Conclusions
Simple, quick and with reasonable cost analytical methods are needed for the better
understanding of our world. In this context, this publication presents a suitable method for
the analysis of EVOO SEC, whose analysis has been a challenge since their characteriza-
tion [54]. The best methods up to now were NMR methods, which despite presenting a
lot of advantages, require a high time- and reagent-consuming extraction of the samples.
Furthermore, there is an UHPLC validated method for EVOO SEC analysis, which uses
a non-generic UHPLC and requires a different sample extraction than the one used for
other EVOO phenolic compounds. Therefore, in this work, a quick (6.5 min) chromato-
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graphic method was developed and validated for the analysis of the main SEC compounds
in EVOO, using the same extraction procedure employed for the other EVOO phenolic
compounds, rendering it low time- and reagent-consuming. The linearity of the method
was between 1 and 20 mg·kg−1, the accuracies were between AOAC accepted margins,
and the LOD and LOQ relatively low (in the order of 20 and 100 µg·kg−1, respectively).
The cleaning step of the chromatographic method was good as the carry-over was null.
This method would provide new tools for a better understanding on how EVOO phenolic
profile changes during extraction and due to agronomical conditions, such as olive variety
or olive maturity stage. Finally, it would help future research to determine better the effect
of EVOO phenolic profile on animal and human health.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/antiox10040540/s1, Figure S1: Chromatograms of a water injection after a sample. Figure S2:
Residual plot of the different calibration curves.
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